Help protect yourself this season

Updated Novavax COVID-19 vaccine (2024-2025 Formula) now available.

Find Novavax's COVID-19 vaccine
Novavax Names New Executive Vice President, Research & Development

Dr. Draghia-Akli brings more that 20 years of expertise to support Novavax's transition to an R&D-focused organization.

Read press release
Collaborating for a Future Free from the Grip of Malaria

As a result of years of dedicated research and effort, children receive the first doses of the R21/Matrix-MTM Malaria vaccine.

Learn more
animated gif of the counties in Africa receiving R21/Matrix-M
Find a vaccine
Updated COVID-19 vaccine (2024-2025 Formula) now available
New EVP, R&D Named
Dr. Ruxandra Draghia-Akli brings more than 20 years of expertise
R21/Matrix-M™ Malaria vaccine
Administration begins in Africa

Information about our vaccine for Healthcare Professionals

Visit our authorization website for information on ordering, efficacy, safety and other information.

Explore resources
Needle icon

Novavax's Investor Hub

Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for investor updates, such as upcoming events and webcasts, daily closing stock price, SEC filings and press releases.

Learn more
View our pipeline
circle graph icon

Latest press releases

View press releases

Blog

What is a protein-based vaccine?

Review the article

Blog

Antibodies and immunity: Does vaccine protection last?

Learn about immunity

Blog

Why do we need an updated vaccine?

Learn about variants